The FDA authorizes COVID-19 shots for infants and preschoolers The vaccinations for children as young as 6 months old could start next week. But first, the Centers for Disease Control and Prevention must sign off. WEKU · Jun 17, 2022
US FDA panel backs first Covid-19 jabs for children under five The first COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday. France 24 · Jun 15, 2022
FDA just authorized Covid-19 vaccines for kids under 5. Here’s what parents need to know An outside panel of experts for the FDA recommended both the Moderna and Pfizer vaccine for kids under 5. Shortly after, the FDA granted a EUA. Inverse · Jun 15, 2022
FDA advisers weigh COVID-19 shots for babies, young children U.S. government advisers met Wednesday to decide whether to endorse COVID-19 shots for the youngest children, moving the nation closer to vaccinations for all ages The Independent UK · Jun 15, 2022
FDA advisers back Novavax COVID-19 shots as new US option A more traditional kind of COVID-19 vaccine has moved a step closer to the U.S. market The Independent UK · Jun 7, 2022
FDA authorizes first COVID booster for children ages 5 to 11 The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot. WEKU · May 17, 2022
US Drug Regulator Limits Use of J&J Covid Vaccine The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition. The vaccine, which was authorized as a single shot,… Asharq Al-Awsat · May 6, 2022
FDA limits use of Johnson & Johnson COVID vaccine over blood clot risks, agency says The use of Johnson and Johnson’s COVID-19 vaccine, also known as Janssen, has been limited to “certain individuals” over rare blood clot risks, the U.S. Food and Drug Administration announced Thursday, May 5. McClatchy Washington Bureau · May 5, 2022
Moderna seeks FDA approval of Covid vaccine for children aged six months to five years old The request arrives one month after the drug company said its two-dose jabs provided immune protection in youngest children The Independent UK · Apr 28, 2022
Moderna seeks to be 1st with COVID shots for littlest kids Moderna is asking U.S. regulators to open its COVID-19 vaccine to the nation's youngest children The Independent UK · Apr 28, 2022
Most Americans have COVID-19 antibodies as case numbers rise - Roll Call The percentage of people with antibodies increased from 34 percent in December to roughly 58 percent in February, the CDC said. Roll Call · Apr 26, 2022
Pryzm owner to open 10 new bars in the UK as nightlife recovers Rekom’s 48 British outlets have seen attendance return to pre-pandemic levels The Guardian - UK · Apr 19, 2022
US experts discuss COVID boosters for the fall and beyond Vaccine experts are meeting to discuss the U.S. strategy for future COVID-19 booster campaigns The Independent UK · Apr 6, 2022
Now is the time to get a second COVID-19 booster shot, health official advises LOS ANGELES — Now is the time for those at higher risk from COVID-19 to get a second booster dose, Los Angeles County’s public health director said, citing less-than-ideal overall vaccination rates along with concerns swirling around the rapid spread of the highly contagious BA.2 omicron subvariant. Los Angeles Times · Apr 1, 2022
The Guardian - US · Mar 30, 2022 ‘This massive undertaking was invisible’: film glimpses behind the curtain as Covid vaccine was made Acclaimed film-maker David France’s How to Survive a Pandemic on HBO documents ‘a scientific undertaking unlike any in our lifetime’
Axios · Mar 30, 2022 America's choose-your-own-adventure vaccine approach could create confusion The gap between the under-vaccinated and the ultra-vaccinated will continue to grow.
Tribune News Service · Mar 29, 2022 FDA clears way for millions to get additional COVID-19 boosters WASHINGTON — U.S. regulators cleared second booster doses of COVID-19 vaccine from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE for adults 50 and older, making millions more people eligible for the shots as concern grows about a potential new wave of infections.